A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age30-60

SponsorBausch Health Americas, Inc.

About this trial

A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System

Be an adult female or male, ≥30 - ≤60 years of age.

Participant is pregnant or breast feeding or trying to become pregnant for 3 months prior to the screening visit or during the study.

164 Participants

are divided into 2 treatment groups

Bausch Health Americas, Inc.

Lead sponsor